AU Stock MarketDetailed Quotes
ILAO Island Pharmaceuticals Ltd
- 0.140
- +0.050+55.56%
20min DelayMarket Closed Nov 27 14:37 AET
21.83MMarket Cap0.00P/E (Static)
0.180High0.130Low387.00KVolume0.130Open0.090Pre Close59.28KTurnover0.18052wk High0.89%Turnover Ratio155.92MShares0.01052wk Low--EPS TTM6.08MFloat Cap0.180Historical High0.00P/E (Static)43.41MShs Float0.010Historical Low--EPS LYR55.56%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
About Island Pharmaceuticals Ltd Company
Island Pharmaceuticals Ltd is a drug research and repurposing company focused on developing preventative or therapeutic drugs for viral infections. Its drug candidate ISLA-101 is a drug with a well-established safety profile, being repurposed for the prevention and treatment of dengue fever and another mosquito (or vector) borne diseases. The company carries out its research and development activities principally in the geographic regions of Australia and the United States of America.
Company Profile
SymbolILAO
Company NameIsland Pharmaceuticals Ltd
Founded2020
MarketASX
Fiscal Year Ends06-30
Addressc/- Bio101 Financial Advisory Pty Ltd 697 Burke Road, Suite 201
CityMelbourne
CountryAustralia
Zip Code3124
Phone+61 370367675
Share RegistryAUTOMIC REGISTRY SERVICES
Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000
02 9698 5414
Company Executives
- Name
- Position
- Salary
- David Foster
- Chief Executive Officer,Executive Director
- --
- Paul MacLeman
- Executive Chairman,Executive Director
- --
- Anna Lavelle
- Non-Executive Director
- --
- Albert Hansen
- Non-Executive Director
- --
- David Lionel Brookes
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data